Amovin is available as 625mg tablets, 1.2g & 600mg injections and 228mg/5ml suspension.
Amovin is a combination of amoxycillin and pottasium clavulanate. Clavulanic acid potentiates amoxycillin and enhances its rapid bactericidal activity against susceptible beta-lactamase producing organisms. Resistant organisms produce beta-lactase enzyme which hydrolyses the beta-lactam ring of the antibiotic, amoxycilin rendering it ineffective. Amovin is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, gynaecological sepsis, etc.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































